AB0444 Description in real-world of the efficacy after switching from intravenous to subcutaneous administration of tocilizumab in patients with rheumatoid arthritis. the roswitch study

J. Darloy, N. Segaud, J.-H. Salmon, V. Goeb, M.-H. Guyot, L. Marguerie, C. Chopin, S. Gally, I. Idier, G. Baudens, R.-M. Flipo
2018 Rheumatoid arthritis – biological DMARDs   unpublished
doi:10.1136/annrheumdis-2018-eular.3411 fatcat:eaflyc2hdrdazlf3dzc7vcf7ty